Documentos relacionados

1. New Biological Therapies for Multiple Myeloma.
2. A real-world data analysis of predictors of early mortality after a diagnosis of multiple myeloma.
3. How to Diagnose, Treat, and Monitor Treatment Response in Patients with Multiple Myeloma.
4. Patient perspectives on considerations, tradeoffs, and experiences with multiple myeloma treatment selection: a qualitative descriptive study.
5. A phase 1 study of ruxolitinib, steroids and lenalidomide for relapsed/refractory multiple myeloma patients.
6. Isolation and Structure Elucidation of Compounds from <i>Sesamum alatum</i> and Their Antiproliferative Activity against Multiple Myeloma Cells.
7. Talquetamab in multiple myeloma.
8. BCMA- or GPRC5D-targeting bispecific antibodies in multiple myeloma: efficacy, safety, and resistance mechanisms.
9. Physician treatment preferences for relapsed/refractory multiple myeloma: a discrete choice experiment.
10. Resolving therapy resistance mechanisms in multiple myeloma by multiomics subclone analysis.